Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Geron Corporation    GERN   US3741631036

Delayed Quote. Delayed  - 07/28 04:00:00 pm
4.22 USD   +3.43%
05/11 GERON : The Shuman Law Firm : Investigates Geron Corp.
05/05 GERON : NASDAQ:GERN) Investor Alert: Investigation over Potential Wr..
04/30 GERON : reports 1Q loss
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/22/2015 07/23/2015 07/24/2015 07/27/2015 07/28/2015 Date
4.32(c) 4.27(c) 4.11(c) 4.08(c) 4.22(c) Last
2 493 185 2 081 104 2 540 045 2 170 505 1 903 100 Volume
+1.53% -1.16% -3.75% -0.73% +3.43% Change
More quotes
Financials ($)
Sales 2015 27,9 M
EBIT 2015 -8,74 M
Net income 2015 -13,6 M
Debt 2015 -
Yield 2015 -
Sales 2016 1,23 M
EBIT 2016 -19,0 M
Net income 2016 -40,6 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 23,9x
Capi. / Sales 2016 544x
Capitalization 667 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
07/15 ASTERIAS BIOTHERAPEUTICS : Patent Issued for Suspension Culture of Human Embryon..
07/15 GERON : Patent Issued for Oligonucleotide Conjugates
05/11 GERON : The Shuman Law Firm : Investigates Geron Corp.
05/06 GERON : Harwood Feffer LLP Announces Investigation of Geron Corporation
05/05 GERON : NASDAQ:GERN) Investor Alert: Investigation over Potential Wrongdoing
04/30 GERON : reports 1Q loss
04/30 Geron Corporation Reports First Quarter 2015 Financial Results and Recent Eve..
04/29 GERON : Harwood Feffer LLP : Announces Investigation of Geron Corporation
More news
Sector news : Bio Therapeutic Drugs
07/28 INTREXON : Oragenics Reports Positive In Vivo Antibiotic Efficacy Data in Critic..
07/28 ISIS PHARMACEUTICALS' : Second Quarter 2015 Financial Results Conference Call (W..
07/28 UNITED THERAPEUTICS : beats 2Q profit forecasts
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
07/21 Geron's Second-Line Myelofibrosis Trial Offers Significant EPS Potential
07/18 Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And B..
07/16 PREMARKET BIOTECH DIGEST : Lure Of Startups, Geron's Short Squeeze, New ODDs
07/09 ORPHAN DRUGS SERIES : Time From ODD To Market Approval
07/02 SEEKING ALPHA'S BIOTECH WEEKLY : Celgene-Juno, Gilead's HIV NDA, Happy 4th!


Comments 
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends GERON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions